Jyske Bank
The share repurchase programme runs as from 28 January 2021 and up to and including 30 September 2021. In this period, Jyske Bank will acquire shares with a value of up to DKK 750 million, cf. Corporate Announcement No. 2/2021 of 28 January 2021. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called "Market Abuse Regulation".
The following transactions have been made under the program:
| Number of shares | Average purchase price (DKK) | Transaction value (DKK) | |
| Accumulated, latest announcement | 593,925 | 255.11 | 151,514,749 |
| 15 March 2021 | 16,000 | 277.51 | 4,440,171 |
| 16 March 2021 | 15,654 | 280.73 | 4,394,568 |
| 17 March 2021 | 15,700 | 280.49 | 4,403,618 |
| 18 March 2021 | 15,750 | 286.18 | 4,507,285 |
| 19 March 2021 | 15,222 | 284.10 | 4,324,512 |
| Accumulated under the programme | 672,251 | 258.21 | 173,584,903 |
With the transactions stated above, Jyske Bank now owns a total of 672,251 of treasury shares, excluding investments made on behalf of customers and shares held for trading purposes, corresponding to 0.93% of the share capital.
In accordance with the EU Commission Regulation No. 596/2014, transactions related to the share buy-back programme are attached to this corporate announcement in detailed form.
Yours faithfully,
Jyske Bank
Contact: Birger Krøgh Nielsen, CFO, tel. +45 89 89 64 44.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Aqua free GmbH14.1.2026 23:18:00 CET | Press release
New site in Lommel, Belgium: Aqua free successfully completes set-up phase with ISO 9001 certification
Teva Pharmaceutical Industries Ltd14.1.2026 23:02:28 CET | Press release
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
Centessa Pharmaceuticals plc14.1.2026 23:00:00 CET | Press release
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting
Infoblox Inc.14.1.2026 21:00:00 CET | Press release
Infoblox Expands Its Preemptive Security Offering to Combat Brand Abuse, Credential Exposure and External Threats with Planned Acquisition of Axur
Soterix Systems Inc.14.1.2026 20:10:01 CET | Press release
Soterix Systems Welcomes Paul Smith as Executive Vice President of Sales, North America
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
